World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
124
Citations
53267
World Ranking
3238
National Ranking
1784

Claudio Anasetti publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Claudio Anasetti sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 699 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Claudio Anasetti D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Claudio Anasetti sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 124 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Claudio Anasetti is affiliated with the Fred Hutchinson Cancer Research Center in the United States and focuses primarily on medical research. Their scholarly work spans several main and subfields within medicine, including hematology, immunology, oncology, public health, environmental and occupational health, and molecular biology.

Their research topics cover a range of areas related to blood disorders and immune system function. Key topics include:

  • Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia research
  • Immune Cell Function and Interaction
  • Acute Myeloid Leukemia Research
  • CAR-T cell therapy research
  • Polyomavirus and related diseases
  • T-cell and B-cell Immunology

They have contributed to numerous publications, frequently collaborating with experts such as Farhad Khimani, Nelli Bejanyan, Taiga Nishihori, Lia Perez, and Asmita Mishra. The scientist's work has appeared extensively in notable journals and venues including:

  • Transplantation and Cellular Therapy
  • Blood
  • Biology of Blood and Marrow Transplantation
  • Clinical Cancer Research
  • Blood Advances

Some recent papers authored or co-authored by Claudio Anasetti include:

  • Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma, 2021, Blood
  • National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide, 2021, Journal of Clinical Oncology
  • Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel, 2020, Clinical Cancer Research
  • Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease, 2020, Journal of Clinical Investigation
  • Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial, 2022, Transplantation and Cellular Therapy

Best Publications

  • High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

    Stephanie J. Lee;John Klein;Michael Haagenson;Lee Ann Baxter-Lowe

  • Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

    Claudio Anasetti;Brent R. Logan;Stephanie J. Lee;Edmund K. Waller

  • Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

    Neal Flomenberg;Lee Ann Baxter-Lowe;Dennis Confer;Marcelo Fernandez-Vina

  • Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

    K M Sullivan;E Agura;C Anasetti;F Appelbaum

  • Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia

    K M Sullivan;P L Weiden;R Storb;R P Witherspoon

  • Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells

    Mario Arpinati;Cherie L. Green;Shelly Heimfeld;Jill E. Heuser

  • A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

    Corey S. Cutler;Stephanie J. Lee;Peter Greenberg;H. Joachim Deeg

  • Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.

    C Anasetti;D Amos;P G Beatty;F R Appelbaum

  • Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.

    Richard A. Nash;Joseph H. Antin;Chatchada Karanes;Joseph W. Fay

  • Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid Leukemia

    John A. Hansen;Theodore A. Gooley;Paul J. Martin;Frederick Appelbaum

  • Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.

    Patrick Tan;Claudio Anasetti;John A. Hansen;Jennifer Melrose

  • Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.

    RA Clift;CD Buckner;FR Appelbaum;SI Bearman

  • Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]

    KM Sullivan;PL Weiden;R Storb;RP Witherspoon

  • Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

    Dietger Niederwieser;Michael Maris;Judith A. Shizuru;Effie Petersdorf

  • Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial.

    R Storb;HJ Deeg;M Pepe;F Appelbaum

  • Optimizing Outcome After Unrelated Marrow Transplantation by Comprehensive Matching of HLA Class I and II Alleles in the Donor and Recipient

    Effie W. Petersdorf;Theodore A. Gooley;Claudio Anasetti;Paul J. Martin

  • A retrospective analysis of therapy for acute graft-versus-host disease

    Paul J. Martin;Gary Schoch;Lloyd Fisher;Vera Byers

  • Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.

    R A Nash;M S Pepe;R Storb;G Longton

  • Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics.

    J T Slattery;J E Sanders;C D Buckner;R L Schaffer

  • Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation

    George B. McDonald;John T. Slattery;Michelle E. Bouvier;Song Ren

Frequent Co-Authors

Paul J. Martin
Paul J. Martin Fred Hutchinson Cancer Research Center
Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
Xue-Zhong Yu
Xue-Zhong Yu Medical College of Wisconsin
Jean E. Sanders
Jean E. Sanders Fred Hutchinson Cancer Research Center
Kristine Doney
Kristine Doney Fred Hutchinson Cancer Research Center
John A. Hansen
John A. Hansen Fred Hutchinson Cancer Research Center
Keith M. Sullivan
Keith M. Sullivan Duke University
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
Effie W. Petersdorf
Effie W. Petersdorf University of Washington
Robert P. Witherspoon
Robert P. Witherspoon Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always require attending traditional, on-campus programs. A variety of medical billing and coding schools online provide the flexibility to start your healthcare journey while balancing other commitments. These programs can lead to rewarding administrative roles and offer options with financial aid.

For aspiring nurses, there are lpn to rn programs without teas test requirements, making it easier for licensed practical nurses to advance without the added stress of standardized testing. This pathway can make nursing education more accessible for many students.

Those interested in leadership or administrative roles might consider the best online healthcare administration degree programs. These streamlined degrees equip graduates with essential management skills for hospitals, clinics, and other health organizations.

Registered nurses looking to become nurse practitioners should explore rn to fnp programs. These bridge programs help RNs earn their Family Nurse Practitioner credentials faster and with more flexibility, opening the door to advanced clinical practice and greater career autonomy.

Best Scientists Citing Claudio Anasetti

Trending Scientists

Recently Published Articles